| Literature DB >> 26894023 |
Jeonghwan Lee1, Seong Woo Lee1, Jae Wook Lee2, Ho Jun Chin3, Kwon Wook Joo1, Yon Su Kim1, Curie Ahn1, Suhnggwon Kim1, Jeong Yeon Cho4, Jin Suk Han1.
Abstract
BACKGROUND: Acute renal failure (ARF) with severe loin pain and patchy renal vasoconstriction (PRV) is a syndrome presenting with sudden loin pain after anaerobic exercise. We aimed to investigate the clinical characteristics and the efficacy of diagnostic imaging studies of patients with this syndrome.Entities:
Keywords: Acute kidney injury; Exercise; Renal hypouricemia; Vasoconstriction
Year: 2012 PMID: 26894023 PMCID: PMC4716092 DOI: 10.1016/j.krcp.2012.06.005
Source DB: PubMed Journal: Kidney Res Clin Pract ISSN: 2211-9132
Clinical characteristics of patients
| ID | Age (y) | Sex | Pain | CVAT | Suspected causes or associated factors of pain | Combined symptoms | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Loin | Back | Abdomen | Exercise | Alcohol | URI | Analgesics | Fever | Vomiting | Headache | Oliguria | ||||
| 1 | 21 | F | + | – | – | – | Track 800 m | – | + | + | – | – | – | + |
| 2 | 21 | M | + | – | – | – | Track 2000 m | – | + | – | – | – | – | – |
| 3 | 17 | M | + | – | + | Right | Track 1000 m | – | – | + | – | – | – | – |
| 4 | 17 | M | – | – | + | – | Track 1000 m | – | + | + | + | + | – | – |
| 5 | 17 | M | + | + | – | Both | Track 1000 m | – | + | – | + | – | + | – |
| 6 | 17 | M | + | + | + | Both | Track 1000 m | – | – | – | + | + | + | + |
| 7 | 18 | M | – | – | + | Right | Track 1000 m | – | + | – | + | + | – | + |
| 8 | 16 | M | + | – | + | Both | Track 200 m | – | – | + | + | + | + | + |
| 9 | 33 | M | + | + | + | Both | – | + | + | – | + | + | + | + |
| 10 | 35 | M | + | + | + | – | Running 600 m | + | – | + | – | – | + | – |
| 11 | 23 | F | – | – | + | Right | – | – | + | – | + | + | – | – |
| 12 | 25 | M | + | + | – | Right | – | – | + | – | + | + | + | – |
| 13 | 32 | M | + | + | + | Left | – | – | – | + | – | – | – | – |
| 14 | 27 | M | – | – | + | Both | Running 1 h | – | + | + | + | – | – | – |
| 15 | 24 | M | + | – | + | Both | Soccer 90 min | – | – | – | – | + | – | + |
| 16 | 18 | M | + | + | + | Both | Running 2000 m | + | – | – | + | + | – | – |
| 17 | 30 | M | – | – | + | – | – | – | – | – | + | – | – | – |
Factors that were combined or not combined with the patient are expressed as + and −, respectively. Six patients (ID 1-6) were previously described [7].
CVAT, costovertebral angel tenderness; F, female; ID, patient identification number; M, male; URI, upper respiratory infections.
Comparison of characteristics in acute renal failure with severe loin pain and patchy renal vasoconstriction
| This study ( | Ishikawa et al. | Ohta et al. | ||||
|---|---|---|---|---|---|---|
| Value | Value | Value | ||||
| Male sex | 17 | 15 (88.2%) | 118 | 112 (94.9%) | 54 | 48 (88.9%) |
| Age (y) | 17 | 23.0±6.5 (16–35) | 118 | 22.0±7.6 (10–54) | 54 | 19.3±8.1 (11–46) |
| Loin pain | 17 | 12 (70.6%) | N/A | N/A | 60 | 35 (58.3%) |
| Abdominal pain | 17 | 13 (76.5%) | N/A | N/A | 60 | 22 (36.7%) |
| Nausea or vomiting | 17 | 14 (82.4%) | 88 | 84 (95.5%) | 60 | 51 (85.0%) |
| Fever | 17 | 11 (64.7%) | 47 | 38 (80.9%) | 60 | 7 (11.7%) |
| Oliguria | 17 | 6 (35.3%) | 102 | 16 (15.7%) | 60 | 0 (0%) |
| Flu-like symptoms before pain | 17 | 9 (52.9%) | 53 | 25 (47.2%) | N/A | N/A |
| Analgesics ingestion before pain | 17 | 7 (41.2%) | 58 | 22 (37.9%) | N/A | N/A |
| Type of exercise | ||||||
| Track race | 17 | 8 (47.1%) | 118 | 79 (66.9%) | 61 | 36 (59.0%) |
| Running | 17 | 3 (17.6%) | 118 | 5 (4.2%) | 61 | 8 (13.1%) |
| Soccer | 17 | 1 (5.9%) | 118 | 9 (7.6%) | 61 | 2 (3.3%) |
| Others | 17 | 0 (0%) | 118 | 25 (21.2%) | 61 | 15 (24.6%) |
| Duration of pain (d) | 17 | 3.5±4.0 (1 –1 6) | 34 | 4.8±3.3 (1 –1 4) | N/A | N/A |
| Duration of renal dysfunction (d) | 17 | 10.8±5.0 (2 –2 2) | 87 | 13.1±8.3 (3 –6 0) | N/A | N/A |
| Dialysis | 17 | 1 (5.9%) | 118 | 20 (16.9%) | N/A | N/A |
| Recurrence | 17 | 0 (0%) | 118 | 20 (16.9%) | 54 | 13 (24.1%) |
| Initial serum creatinine (mg/dL) | 17 | 4.64±2.84 (1.3–12.1) | 77 | 4.70±2.90 (1.1–15.0) | N/A | N/A |
| Maximal serum creatinine (mg/dL) | 17 | 5.42±3.16 (1.4–12.1) | 109 | 6.00±3.00 (1.2–15.0) | 68 | 5.45±3.33 (1.1–17.7) |
| Maximal serum uric acid (mg/dL) | 17 | 9.41±2.91 (6.0–15.8) | N/A | N/A | 59 | 4.40±2.49 (0.4–13.3) |
| Serum uric acid after recovery (mg/dL) | 17 | 5.49±2.08 (1.5–7.2) | N/A | N/A | 54 | 0.70±0.25 (0.1–1.4) |
| Proportion of renal hypouricemia | 7 | 1 (14.3%) | 96 | 49 (51.0%) | 48 | 48 (100%) |
| CT scan of patchy lesions | 17 | 17 (100%) | 50 | 46 (92.0%) | N/A | N/A |
| Bone scan of patchy lesions | 10 | 8 (80%) | 20 | 12 (60.0%) | N/A | N/A |
| MRI of patchy lesions | 3 | 3 (100%) | N/A | N/A | N/A | N/A |
Values are expressed with mean±standard deviation with (range) or the number of positive cases with (percent).
CT, computed tomography; MRI, magnetic resonance imaging; N, number of patients included in each study; n, number of cases; N/A, not available.
Number and percent of patients who experienced the applicable symptom as an initial presentation.
Laboratory findings of patients
| ID | Maximal BUN (mg/dL) | Maximal creatinine (mg/dL) | Maximal uric acid (mg/dL) | Creatinine at discharge (mg/dL) | Minimal uric acid (mg/dL) | Maximal myoglobin (ng/mL) | Maximal CPK(IU/L) | Maximal LDH (IU/L) |
|---|---|---|---|---|---|---|---|---|
| 1 | 61 | 11.9 | 12.0 | N/A | N/A | N/A | N/A | N/A |
| 2 | 28 | 3.1 | 8.4 | N/A | N/A | 48 | 57 | 253 |
| 3 | 12 | 2.1 | 7.2 | 1.2 | N/A | 77 | 363 | 227 |
| 4 | 19 | 4.2 | 11.1 | 1.4 | N/A | 10 | 498 | 223 |
| 5 | 51 | 7.4 | 7.4 | 1.5 | N/A | 182 | 423 | 400 |
| 6 | 44 | 5.6 | 13.0 | 1.3 | 6.4 | 92 | 155 | 184 |
| 7 | 66 | 8.3 | 13.2 | N/A | N/A | N/A | 142 | 347 |
| 8 | 67.4 | 12.1 | 15.8 | N/A | N/A | N/A | 546 | N/A |
| 9 | 50 | 5.7 | N/A | 1.5 | N/A | N/A | 140 | 170 |
| 10 | 28 | 3.0 | 6.6 | 1.2 | 6.1 | N/A | 124 | 190 |
| 11 | 26 | 2.6 | 8.0 | 1.6 | N/A | N/A | N/A | N/A |
| 12 | 31 | 4.1 | 9.1 | 1.3 | 7.2 | N/A | N/A | N/A |
| 13 | 28 | 4.7 | 8.0 | 1.6 | 6.8 | N/A | 38 | 188 |
| 14 | 29 | 7.6 | 10.9 | 1.6 | 6.6 | 31.5 | 52 | 256 |
| 15 | 20 | 3.0 | 6.3 | 1.2 | 3.8 | 57.9 | 360 | N/A |
| 16 | 41 | 5.4 | 6.0 | 1.4 | 1.5 | 123.9 | 281 | 199 |
| 17 | 13 | 1.4 | 7.5 | 1.3 | N/A | N/A | N/A | N/A |
Six patients (ID 1-6) were previously described [7].
BUN, blood urea nitrogen; CPK, creatinine phosphokinase; LDH, lactate dehydrogenase; N/A, not available.
Findings of the imaging studies
| ID | Contrast-enhanced CT | Bone scan (d) | MRI (d) | |
|---|---|---|---|---|
| CT contrast (d) | CT delay (h) | |||
| 1 | Diffusely enhanced (12) | Patchy high (48) | Diffuse and delayed uptake (12) | Not done |
| 2 | Patchy low (10) | Patchy high (24) | Patchy (9) | Not done |
| 3 | Patchy low (5) | Patchy high (24) | Patchy (3) | Not done |
| 4 | Diffusely enhanced (4) | Patchy high (24) | Patchy (3) | T1, focal patchy (7) |
| 5 | Diffusely enhanced (11) | Patchy high (24) | Patchy (10) | T1/T2, focal increased intensity (11) |
| 6 | Diffusely enhanced (6) | Patchy high (24) | Patchy (6) | Not done |
| 7 | Patchy low (7) | Patchy high (24) | Diffuse and delayed uptake (8) | Not done |
| 8 | Patchy low (18) | Patchy high (24) | Not done | T1, wedge-shaped low signal (20) |
| 9 | Patchy low (1) | Patchy high (48) | Patchy (5) | Not done |
| 10 | Patchy low (1) | Patchy high (24) | Not done | Not done |
| 11 | Patchy low (4) | Patchy high (4) | Not done | Not done |
| 12 | Patchy low (4) | Patchy high (24) | Not done | Not done |
| 13 | Patchy low (8) | Patchy high (24) | Not done | Not done |
| 14 | Diffusely enhanced (4) | Patchy high (48) | Not done | Not done |
| 15 | Patchy low (5) | Patchy high (48) | Patchy (4) | Not done |
| 16 | Patchy low (5) | Patchy high (4) | Patchy (4) | Not done |
| 17 | Patchy low (5) | Patchy high (24) | Not done | Not done |
The findings of imaging studies are summarized. Six patients (ID 1-6) were previously described [7].
Diffusely enhanced, diffuse enhancement without focal lesions; ID, patient identification number; patchy high, multiple patchy areas with high attenuation; patchy low, multiple patchy areas with low attenuation.
Day after the onset of pain.
Hour after contrast enhancement.
Figure 1Computed tomography images of a patient with acute renal failure with severe loin pain and patchy renal vasoconstriction. (A) On an image taken immediately after contrast media injection (patient ID 16), multiple wedge-shaped low attenuated lesions (depicted as wedges) are observed on both kidney areas. (B) On a delayed image taken after 4 h (patient ID 16), the areas that were initially shown as low attenuated lesions changed to highly attenuated wedge-shaped patchy lesions (depicted as arrows).
Figure 2Bone scan findings using 99 mTc-MDP in patients with acute renal failure with severe loin pain and patchy renal vasoconstriction. (A and B) Posterior views of bone scintigraphy (patient IDs 16 and 15, respectively) taken 4 hours after the administration of technetium-99 m methylene diphosphonate. Images show diffusely increased uptake and delayed excretion of radioisotopes in the areas of both renal cortexes. Multiple areas of patchy isotope accumulation are observed (depicted as arrows).